Allogene Therapeutics Statistics
Total Valuation
ALLO has a market cap or net worth of $258.10 million. The enterprise value is $66.98 million.
Important Dates
The next estimated earnings date is Wednesday, August 6, 2025, after market close.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
ALLO has 218.73 million shares outstanding. The number of shares has increased by 26.55% in one year.
| Current Share Class | 218.73M |
| Shares Outstanding | 218.73M |
| Shares Change (YoY) | +26.55% |
| Shares Change (QoQ) | +2.27% |
| Owned by Insiders (%) | 9.29% |
| Owned by Institutions (%) | 72.54% |
| Float | 157.19M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| Forward PS | 25,304.15 |
| PB Ratio | 0.73 |
| P/TBV Ratio | 0.67 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 9.71, with a Debt / Equity ratio of 0.23.
| Current Ratio | 9.71 |
| Quick Ratio | 9.40 |
| Debt / Equity | 0.23 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -764.86 |
Financial Efficiency
Return on equity (ROE) is -59.60% and return on invested capital (ROIC) is -30.68%.
| Return on Equity (ROE) | -59.60% |
| Return on Assets (ROA) | -28.92% |
| Return on Invested Capital (ROIC) | -30.68% |
| Return on Capital Employed (ROCE) | -52.97% |
| Revenue Per Employee | n/a |
| Profits Per Employee | -$1.10M |
| Employee Count | 229 |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, ALLO has paid $443,000 in taxes.
| Income Tax | 443,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -49.57% in the last 52 weeks. The beta is 0.31, so ALLO's price volatility has been lower than the market average.
| Beta (5Y) | 0.31 |
| 52-Week Price Change | -49.57% |
| 50-Day Moving Average | 1.31 |
| 200-Day Moving Average | 1.97 |
| Relative Strength Index (RSI) | 40.77 |
| Average Volume (20 Days) | 2,688,386 |
Short Selling Information
The latest short interest is 26.04 million, so 11.91% of the outstanding shares have been sold short.
| Short Interest | 26.04M |
| Short Previous Month | 24.57M |
| Short % of Shares Out | 11.91% |
| Short % of Float | 16.57% |
| Short Ratio (days to cover) | 7.91 |
Income Statement
| Revenue | n/a |
| Gross Profit | -190.24M |
| Operating Income | -253.17M |
| Pretax Income | -251.88M |
| Net Income | -252.32M |
| EBITDA | -239.99M |
| EBIT | -253.17M |
| Earnings Per Share (EPS) | -$1.22 |
Full Income StatementBalance Sheet
The company has $280.04 million in cash and $88.92 million in debt, giving a net cash position of $191.12 million or $0.87 per share.
| Cash & Cash Equivalents | 280.04M |
| Total Debt | 88.92M |
| Net Cash | 191.12M |
| Net Cash Per Share | $0.87 |
| Equity (Book Value) | 385.39M |
| Book Value Per Share | 1.76 |
| Working Capital | 261.55M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$197.33 million and capital expenditures -$785,000, giving a free cash flow of -$198.12 million.
| Operating Cash Flow | -197.33M |
| Capital Expenditures | -785,000 |
| Free Cash Flow | -198.12M |
| FCF Per Share | -$0.91 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
ALLO does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.55% |
| Shareholder Yield | -26.55% |
| Earnings Yield | -97.76% |
| FCF Yield | -76.76% |
Analyst Forecast
The average price target for ALLO is $8.44, which is 615.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $8.44 |
| Price Target Difference | 615.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 9 |
| Revenue Growth Forecast (5Y) | 608.29% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
ALLO has an Altman Z-Score of -3.72 and a Piotroski F-Score of 1. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -3.72 |
| Piotroski F-Score | 1 |
